A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus infection developed drug resistance. A nebulized treatment based on Zanamivir aqueous solution was started and carried out for ten days resulting in clinical improvement and viral clearance without significant side effects. See attached file
Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
DA DALT, LIVIANA;CALISTRI, ARIANNA;FRANCHIN, ELISA;SALATA, CRISTIANO;PALU', GIORGIO
2010
Abstract
A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus infection developed drug resistance. A nebulized treatment based on Zanamivir aqueous solution was started and carried out for ten days resulting in clinical improvement and viral clearance without significant side effects. See attached file
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Da Dalt et al 2010.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
114.72 kB
Formato
Adobe PDF
|
114.72 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
